Tag - PRTG

Cantor Fitzgerald launched coverage of Portage Biotech (NASDAQ:PRTG) with an “overweight” rating and $35 price target. The stock closed at $18.95 on Aug. 18.  Portage Biotech is a clinical biopharmaceutical company...